Impeto Medical patented technology measures the capacity of the autonomic sweat glands to release chloride ions in response to an electrochemical stimulus. It is a dynamic test.
A low voltage potential of variable amplitude is applied to sensors on regions of the skin with a high density of sweat glands (hands and feet) to stimulate the sweat glands, extract chloride ions and produce a current. This ensures that measurements correspond to the local sweat function. The technology provides a quantitative measure of chloride sweat conductance (measured in microsiemens) and its results serve as a biomarker to assess sweat gland function in relation to sweat gland innervation.
Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive – SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12